UPDATE 2-GSK's two-drug HIV treatment meets main goal in late stage studies
June 14, 2018 at 08:38 AM EDT
June 14 (Reuters) - GlaxoSmithKline's two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the medical field.